- Report
- October 2024
- 180 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
Anethole trithione is a gastrointestinal drug used to treat a variety of digestive disorders, including irritable bowel syndrome, diverticulitis, and Crohn's disease. It is a derivative of thiophene, a sulfur-containing aromatic compound, and is believed to act as an antispasmodic, reducing the frequency and intensity of abdominal cramps. It is also thought to reduce inflammation in the gastrointestinal tract, which can help reduce symptoms of digestive disorders.
Anethole trithione is available in both oral and topical forms, and is often used in combination with other medications to treat digestive disorders. It is generally well-tolerated, with few side effects reported.
The anethole trithione market is a growing one, with many companies offering products containing the drug. Some of these companies include GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more